Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis Remission
NCT07752446 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2026-08-07
Summary
This study will evaluate whether a 12-week dietary intervention can improve gut health, inflammation, and quality of life in adults with ulcerative colitis in remission.
Participants will be randomly assigned to one of three groups: a Mediterranean diet, a Mediterranean diet combined with time-restricted feeding (eating within an 8-hour window each day), or standard dietary advice. The Mediterranean diet emphasizes fruits, vegetables, whole grains, legumes, nuts, olive oil, and fish, while limiting processed foods and red meat.
The main outcome will be changes in short-chain fatty acids in stool samples, which are markers of gut health. Additional outcomes include changes in inflammation markers, gastrointestinal symptoms, and quality of life.
The results of this study may help identify effective dietary strategies to support patients with ulcerative colitis.
Conditions
- Ulcerative Colitis (Disorder)
- Inflammatory Bowel Disease (IBD)
Interventions
- BEHAVIORAL
-
Mediterranean Diet
Participants will receive individualized nutritional counseling to follow a Mediterranean diet, emphasizing high intake of fruits, vegetables, whole grains, legumes, nuts, olive oil, and fish, and reduced consumption of red meat and ultra-processed foods. Dietary plans will be tailored to individual energy requirements.
- BEHAVIORAL
-
Mediterranean Diet + Time-Restricted Feeding
Participants will follow a time-restricted feeding protocol (16:8), consisting of a daily 16-hour fasting period and an 8-hour eating window (12:00-20:00). During the eating window, participants will consume meals based on Mediterranean diet guidelines, with individualized dietary counseling to ensure adequate nutritional intake.
- BEHAVIORAL
-
Standard Dietary Advice
Participants will receive standard dietary counseling based on current clinical guidelines for ulcerative colitis. This includes general recommendations for a balanced diet without specific emphasis on Mediterranean dietary patterns or time-restricted feeding.
Sponsors & Collaborators
-
Pontificia Universidad Catolica de Chile
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-10
- Primary Completion
- 2027-04-10
- Completion
- 2027-06-01
Countries
- Chile
Study Locations
More Related Trials
-
Reduced Sulfur Diet in Ulcerative Colitis Patients
NCT04474561 ·Status: COMPLETED ·Phase: NA
-
Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease
NCT03266484 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies
NCT06906445 ·Status: RECRUITING ·Phase: NA
-
Diet Study on Ulcerative Colitis
NCT04147598 ·Status: COMPLETED ·Phase: NA
-
Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis
NCT02921555 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Gluten Free Diet in Ulcerative Colitis
NCT06249763 ·Status: COMPLETED ·Phase: NA
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
NCT05230173 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis
NCT06895252 ·Status: RECRUITING ·Phase: NA
-
LFMT vs Placebo in New Biologic Start for Ulcerative Colitis
NCT05327790 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease
NCT02801240 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis
NCT07080034 ·Status: RECRUITING ·Phase: PHASE2
-
Personalized "Alberta" Diet for Prevention of Relapse in Ulcerative Colitis
NCT02093780 ·Status: COMPLETED ·Phase: NA
-
Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy(PRECAL)
NCT07721441 ·Status: ENROLLING_BY_INVITATION
-
Diet as Essential Therapy (DIET) for Inflammatory Bowel Disease
NCT03012542 ·Status: UNKNOWN ·Phase: NA
-
Determination of the Optimal Treatment Target in Ulcerative Colitis
NCT04259138 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Prognosis in UC After First Biological
NCT05530122 ·Status: COMPLETED
-
Study of Dietary Composition in Crohn's Disease
NCT04431700 ·Status: TERMINATED ·Phase: NA
-
Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.
NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Impact of Time Restricted Feeding in Crohn's Disease
NCT04271748 ·Status: COMPLETED ·Phase: NA
-
Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis
NCT07744646 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis
NCT03653026 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Disease Activity and Nutrition Treat on Postoperative Recurrence and Complications After Bowel Resection for Crohn's Disease
NCT01540942 ·Status: COMPLETED ·Phase: NA
-
Effect of FAn-7 in UC Activity
NCT01771224 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Predicting Biologic Therapy Success in Ulcerative Colitis Using Intestinal Ultrasound and Fat Assessment
NCT07126015 ·Status: NOT_YET_RECRUITING